| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10907492 | Experimental Hematology | 2005 | 8 Pages |
Abstract
The results suggest that sustained administration of TGF-β1 may be more effective in suppressing terminal differentiation than intermittent dosing and thus effective for cartilage repair.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Koichiro Kawamura, Constance R. Chu, Satoshi Sobajima, Paul D. Robbins, Freddie H. Fu, Nicholas J. Izzo, Christopher Niyibizi,